Effects of Miglitol, Acarbose, and Sitagliptin on Plasma Insulin and Gut Peptides in Type 2 Diabetes Mellitus: A Crossover Study
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Effects of Miglitol, Acarbose, and Sitagliptin on Plasma Insulin and Gut Peptides in Type 2 Diabetes Mellitus: A Crossover Study
Authors
Keywords
Acarbose, Glucagon-like peptide-1, Glucose-dependent insulinotropic polypeptide, Insulin, Japanese patients, Miglitol, Sitagliptin, Type 2 diabetes mellitus
Journal
Diabetes Therapy
Volume 6, Issue 2, Pages 187-196
Publisher
Springer Nature
Online
2015-06-08
DOI
10.1007/s13300-015-0113-3
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Regional, age and sex differences in baseline characteristics of patients enrolled in the Trial Evaluating Cardiovascular Outcomes with Sitagliptin (TECOS)
- (2015) M. A. Bethel et al. DIABETES OBESITY & METABOLISM
- A nomogram to estimate the HbA1c response to different DPP-4 inhibitors in type 2 diabetes: a systematic review and meta-analysis of 98 trials with 24 163 patients
- (2015) K. Esposito et al. BMJ Open
- Specificity and sensitivity of commercially available assays for glucagon and oxyntomodulin measurement in humans
- (2014) Monika J Bak et al. EUROPEAN JOURNAL OF ENDOCRINOLOGY
- Distinct action of the α-glucosidase inhibitor miglitol on SGLT3, enteroendocrine cells, and GLP1 secretion
- (2014) Eun Young Lee et al. JOURNAL OF ENDOCRINOLOGY
- Diabetes: a 21st century challenge
- (2013) Paul Z Zimmet et al. Lancet Diabetes & Endocrinology
- Anorexigenic Effects of Miglitol in Concert with the Alterations of Gut Hormone Secretion and Gastric Emptying in Healthy Subjects
- (2012) H. Kaku et al. HORMONE AND METABOLIC RESEARCH
- Linagliptin Increases Incretin Levels, Lowers Glucagon, and Improves Glycemic Control in Type 2 Diabetes Mellitus
- (2012) Thomas Rauch et al. Diabetes Therapy
- Comparisons of the effects of 12-week administration of miglitol and voglibose on the responses of plasma incretins after a mixed meal in Japanese type 2 diabetic patients
- (2011) T. Narita et al. DIABETES OBESITY & METABOLISM
- Effect of sitagliptin monotherapy on serum total ghrelin levels in people with type 2 diabetes
- (2011) Özen Öz Gül et al. DIABETES RESEARCH AND CLINICAL PRACTICE
- Analysis of plasma ghrelin in patients with medium-chain acyl-CoA dehydrogenase deficiency and glutaric aciduria type II
- (2011) Takashi Akamizu et al. EUROPEAN JOURNAL OF ENDOCRINOLOGY
- Comparison of incretin immunoassays with or without plasma extraction: Incretin secretion in Japanese patients with type 2 diabetes
- (2011) Daisuke Yabe et al. Journal of Diabetes Investigation
- Incretin-based therapy: a powerful and promising weapon in the treatment of type 2 diabetes mellitus
- (2011) Chrysi Koliaki et al. Diabetes Therapy
- Incretin responses to oral glucose load in Japanese non-obese healthy subjects
- (2011) Etsuko Nagai et al. Diabetes Therapy
- Carbohydrate and fat digestion is necessary for maximal suppression of total plasma ghrelin in healthy adults
- (2010) Kamilia Tai et al. APPETITE
- Single Administration of α-Glucosidase Inhibitors on Endothelial Function and Incretin Secretion in Diabetic Patients With Coronary Artery Disease
- (2010) Makoto Hiki et al. CIRCULATION JOURNAL
- Dipeptidyl Peptidase-4 Inhibitors Administered in Combination With Metformin Result in an Additive Increase in the Plasma Concentration of Active GLP-1
- (2010) E M Migoya et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Effects of miglitol, sitagliptin or their combination on plasma glucose, insulin and incretin levels in non-diabetic men
- (2010) Kazutaka Aoki et al. ENDOCRINE JOURNAL
- Preprandial Single Oral Dose of Sitagliptin Does Not Affect Circulating Ghrelin and Gastrin Levels in Normal Subjects
- (2010) Chen-Ling Huang et al. PHARMACOLOGY
- Evidence for beneficial effects of compromised gastric inhibitory polypeptide action in obesity-related diabetes and possible therapeutic implications
- (2009) N. Irwin et al. DIABETOLOGIA
- Miglitol induces prolonged and enhanced glucagon-like peptide-1 and reduced gastric inhibitory polypeptide responses after ingestion of a mixed meal in Japanese Type 2 diabetic patients
- (2008) T. Narita et al. DIABETIC MEDICINE
- Miglitol suppresses the postprandial increase in interleukin 6 and enhances active glucagon-like peptide 1 secretion in viscerally obese subjects
- (2008) Masayuki Arakawa et al. METABOLISM-CLINICAL AND EXPERIMENTAL
Become a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get StartedAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started